News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
876,922 Results
Type
Article (88397)
Company Profile (812)
Press Release (787685)
Multimedia
Podcasts (219)
Webinars (34)
Section
Business (233424)
Career Advice (4155)
Deals (39921)
Drug Delivery (167)
Drug Development (91550)
Employer Resources (207)
FDA (18482)
Job Trends (17457)
News (398338)
Policy (40006)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (3)
Academia (3035)
Academic (2)
Accelerated approval (46)
Adcomms (37)
Allergies (175)
Alliances (56985)
ALS (208)
Alzheimer's disease (1895)
Antibody-drug conjugate (ADC) (426)
Approvals (18720)
Artificial intelligence (752)
Autoimmune disease (255)
Automation (55)
Bankruptcy (407)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (223)
Biotechnology (486)
Bladder cancer (187)
Brain cancer (75)
Breast cancer (736)
Cancer (5738)
Cardiovascular disease (511)
Career advice (3584)
Career pathing (47)
CAR-T (333)
CDC (72)
Celiac Disease (2)
Cell therapy (925)
Cervical cancer (45)
Clinical research (77938)
Collaboration (2120)
Company closure (7)
Compensation (1333)
Complete response letters (93)
COVID-19 (3018)
CRISPR (111)
C-suite (1079)
Cystic fibrosis (161)
Data (7323)
Decentralized trials (3)
Denatured (82)
Depression (179)
Dermatology (65)
Diabetes (595)
Diagnostics (7419)
Digital health (59)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (375)
Drug pricing (239)
Drug shortages (38)
Duchenne muscular dystrophy (286)
Earnings (101348)
Editorial (72)
Employer branding (25)
Employer resources (174)
Events (136625)
Executive appointments (1119)
FDA (22101)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (33)
Funding (1765)
Gene editing (239)
Generative AI (84)
Gene therapy (758)
GLP-1 (1215)
Government (5514)
Grass and pollen (8)
Guidances (403)
Healthcare (21040)
HIV (82)
Huntington's disease (58)
IgA nephropathy (96)
Immunology and inflammation (330)
Immuno-oncology (95)
Indications (162)
Infectious disease (3372)
Inflammatory bowel disease (223)
Inflation Reduction Act (17)
Influenza (141)
Intellectual property (286)
Interviews (817)
IPO (17976)
IRA (61)
Job creations (5204)
Job search strategy (2869)
JPM (73)
Kidney cancer (20)
Labor market (105)
Layoffs (669)
Leadership (46)
Legal (10169)
Liver cancer (106)
Longevity (30)
Lung cancer (766)
Lymphoma (417)
Machine learning (57)
Management (66)
Manufacturing (1037)
MASH (195)
Medical device (15162)
Medtech (15246)
Mergers & acquisitions (23133)
Metabolic disorders (1605)
mRNA (218)
Multiple sclerosis (184)
NASH (24)
Neurodegenerative disease (439)
Neuropsychiatric disorders (117)
Neuroscience (3443)
Neurotech (2)
NextGen: Class of 2026 (7713)
Non-profit (5131)
Now hiring (75)
Obesity (783)
Opinion (358)
Ovarian cancer (197)
Pain (253)
Pancreatic cancer (270)
Parkinson's disease (371)
Partnered (39)
Patents (593)
Patient recruitment (635)
Peanut (65)
People (67459)
Pharmaceutical (138)
Pharmacy benefit managers (36)
Phase 1 (24075)
Phase 2 (33835)
Phase 3 (25464)
Pipeline (7497)
Policy (372)
Postmarket research (3555)
Preclinical (10799)
Press Release (72)
Prostate cancer (293)
Psychedelics (61)
Radiopharmaceuticals (333)
Rare diseases (1125)
Real estate (7446)
Recruiting (81)
Regulatory (29721)
Reports (74)
Research institute (2756)
Resumes & cover letters (653)
Rett syndrome (34)
RNA editing (23)
RSV (96)
Schizophrenia (178)
Series A (294)
Series B (218)
Service/supplier (30)
Sickle cell disease (115)
Special edition (29)
Spinal muscular atrophy (186)
Sponsored (52)
Startups (4350)
State (2)
Stomach cancer (21)
Supply chain (134)
Tariffs (103)
The Weekly (134)
Vaccines (1237)
Venture capital (111)
Weight loss (536)
Women's health (119)
Worklife (23)
Date
Today (104)
Last 7 days (567)
Last 30 days (2740)
Last 365 days (32836)
2026 (9252)
2025 (33227)
2024 (38126)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1292)
Alabama (100)
Alaska (7)
Arizona (372)
Arkansas (15)
Asia (51904)
Australia (9118)
California (12889)
Canada (3657)
China (1350)
Colorado (557)
Connecticut (565)
Delaware (391)
Europe (119512)
Florida (1927)
Georgia (422)
Hawaii (4)
Idaho (69)
Illinois (1101)
India (91)
Indiana (606)
Iowa (24)
Japan (516)
Kansas (138)
Kentucky (51)
Louisiana (44)
Maine (86)
Maryland (1592)
Massachusetts (9452)
Michigan (393)
Minnesota (731)
Mississippi (7)
Missouri (156)
Montana (37)
Nebraska (30)
Nevada (143)
New Hampshire (90)
New Jersey (3473)
New Mexico (33)
New York (3423)
North Carolina (1760)
North Dakota (10)
Northern California (6282)
Ohio (400)
Oklahoma (26)
Oregon (54)
Pennsylvania (2582)
Puerto Rico (28)
Rhode Island (53)
South America (1668)
South Carolina (81)
South Dakota (1)
Southern California (5031)
Tennessee (206)
Texas (2078)
United States (46456)
Utah (389)
Vermont (1)
Virginia (329)
Washington D.C. (88)
Washington State (1067)
West Virginia (4)
Wisconsin (144)
Wyoming (2)
There are 876,922 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sharp Therapeutics Updates on ‘901 for Gaucher and GBA1 Parkinson’s and Platform Programs
April 10, 2026
·
4 min read
Press Releases
Sharp Therapeutics Announces Closing of Fourth Tranche of Unsecured Convertible Note Offering
April 10, 2026
·
5 min read
Complete response letters
Replimune’s advanced melanoma drug rebuffed by FDA for second time
The FDA in a complete response letter to Replimune maintained its original objection to the single-arm trial the biotech used to support the application for RP1.
April 10, 2026
·
2 min read
·
Heather McKenzie
Press Releases
Younet AI Partners with Perpetuals.com to License and Co-Develop Forgentiq.ai Sovereign LLM and Agentic Technology Platform
Strategic Partnership Positions Both Companies at the Forefront of Institutional-Grade Digital Asset Market Infrastructure Anthropic-Broadcom Landmark Deal Securing 3.5 Gigawatts of TPU Capacity Validates the AI Infrastructure Thesis and Confirms Announced Today Vision of Enterprise-Grade Private AI as the Defining Asset Class of This Decade
April 10, 2026
·
7 min read
Press Releases
Theralase(R) Closes $CAN 2.66 Million Financing
April 10, 2026
·
6 min read
Press Releases
START Strengthens Dallas-Fort Worth Leadership with Dr. Salwan Al Mutar as Director of Clinical Research
April 10, 2026
·
1 min read
Press Releases
Background Check Anxiety: 7 Myths Ruining Your Job Search
April 10, 2026
·
1 min read
Press Releases
Biotechnology & Pharmaceutical Services Outsourcing Market to Reach USD 89.82 Billion by 2035 | 5.7% CAGR Growth
April 10, 2026
·
1 min read
Editorial
With oral obesity race underway, all eyes are on Lilly’s Foundayo launch
Novo Nordisk’s oral Wegovy has a few months’ head start on Eli Lilly’s newly approved pill. While the Indianapolis pharma has come from behind the Danish rival in the weight loss space before, last time it clearly had the better drug.
April 10, 2026
·
3 min read
·
Jef Akst
Press Releases
Michael J. Fox Foundation CEO Deborah W. Brooks and Patient Council Member Israel Robledo Appointed to Federal Advisory Council to Guide First-Ever U.S. Parkinson’s Strategy
April 10, 2026
·
5 min read
1 of 87,693
Next
